{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T07:10:11Z","timestamp":1719731411331},"reference-count":21,"publisher":"Jaypee Brothers Medical Publishing","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.4103\/ijccm.ijccm_177_17","type":"journal-article","created":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T12:23:20Z","timestamp":1514895800000},"page":"857-860","source":"Crossref","is-referenced-by-count":3,"title":["Plasmapheresis: A retrospective audit of procedures from a tertiary care center in Southern India"],"prefix":"10.5005","volume":"21","author":[{"given":"O. T.","family":"Ahammed Nizar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratheeksha","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shobhana","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","published-online":{"date-parts":[[2017]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"1. Kaplan AA. Therapeutic plasma exchange: Core curriculum 2008. Am J Kidney Dis 2008;52:1180-96.","DOI":"10.1053\/j.ajkd.2008.02.360"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"2. Strauss RG, Ciavarella D, Gilcher RO, Kasprisin DO, Kiprov DD, Klein HG, et al. An overview of current management. J Clin Apher 1993;8:189-94.","DOI":"10.1002\/jca.2920080402"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"3. Schwartz J, Padmanabhan A, Aqui N, Balogun RA, Connelly-Smith L, Delaney M, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American Society for Apheresis: The Seventh Special Issue. J Clin Apher 2016;31:149-62.","DOI":"10.1002\/jca.21470"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"4. Korach JM, Berger P, Giraud C, Le Perff-Desman C, Chillet P. Role of replacement fluids in the immediate complications of plasma exchange. French Registry Co-operative Group. Intensive Care Med 1998;24:452-8.","DOI":"10.1007\/s001340050595"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"5. Goto H, Matsuo H, Nakane S, Izumoto H, Fukudome T, Kambara C, et al. Plasmapheresis affects T helper type-1\/T helper type-2 balance of circulating peripheral lymphocytes. Ther Apher 2001;5:494-6.","DOI":"10.1046\/j.1526-0968.2001.00386.x"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"6. Reeves JH, Butt WW, Shann F, Layton JE, Stewart A, Waring PM, et al. Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group. Crit Care Med 1999;27:2096-104.","DOI":"10.1097\/00003246-199910000-00003"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"7. Couriel D, Weinstein R. Complications of therapeutic plasma exchange: A recent assessment. J Clin Apher 1994;9:1-5.","DOI":"10.1002\/jca.2920090102"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"8. Mokrzycki MH, Kaplan AA. Therapeutic plasma exchange: Complications and management. Am J Kidney Dis 1994;23:817-27.","DOI":"10.1016\/S0272-6386(12)80135-1"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"9. van der Mech\u00e9 FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. Dutch Guillain-Barr\u00e9 study group. N Engl J Med 1992;326:1123-9.","DOI":"10.1056\/NEJM199204233261705"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"10. Cortese I, Chaudhry V, So YT, Cantor F, Cornblath DR, Rae-Grant A. Evidence \u2013 Based guidelines update. Plasmapheresis in neurologic disorders: Reports of the Therapeutics and Technology Assessment subcommittee of the American Academy of Neurology. Neurology 2011;76:294-300.","DOI":"10.1212\/WNL.0b013e318207b1f6"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"11. Basic-Jukic N, Brunetta B, Kes P. Plasma exchange in elderly patients. Ther Apher Dial 2010;14:161-5.","DOI":"10.1111\/j.1744-9987.2009.00793.x"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"12. Stegmayr B, Ptak J, Wikstr\u00f6m B, Berlin G, Axelsson CG, Griskevicius A, et al. World apheresis registry 2003-2007 data. Transfus Apher Sci 2008;39:247-54.","DOI":"10.1016\/j.transci.2008.09.003"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"13. Srivastava R, Gupta RC, Khatri PC, Lalchandani A. Changing scenario of therapeutic apheresis in India in the last 14 years. Ther Apher 1998;2:317-9.","DOI":"10.1111\/j.1744-9987.1998.tb00132.x"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"14. Vucic S, Davies L. Safety of plasmapheresis in the treatment of neurological disease. Aust N Z J Med 1998;28:301-5.","DOI":"10.1111\/j.1445-5994.1998.tb01952.x"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"15. Shemin D, Briggs D, Greenan M. Complications of therapeutic plasma exchange: A prospective study of 1,727 procedures. J Clin Apher 2007;22:270-6.","DOI":"10.1002\/jca.20143"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"16. Ward DM. Conventional apheresis therapies: A review. J Clin Apher 2011;26:230-8.","DOI":"10.1002\/jca.20302"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"17. Sharma RR, Saluja K, Jain A, Dhawan HK, Thakral B, Marwaha N, et al. Scope and application of therapeutic apheresis: Experience from a tertiary care hospital in North India. Transfus Apher Sci 2011;45:239-45.","DOI":"10.1016\/j.transci.2011.09.002"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"18. Gafoor VA, Jose J, Saifudheen K, Musthafa M. Plasmapheresis in neurological disorders: Experience from a tertiary care hospital in South India. Ann Indian Acad Neurol 2015;18:15-9.","DOI":"10.4103\/0972-2327.144301"},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"19. Vikrant S, Thakur S, Sharma A, Gupta D, Sharma S. Safety and efficacy of therapeutic membrane plasmapheresis in the treatment of Guillain-Barr\u00e9 syndrome: A study from a tertiary care hospital from India. Neurol India 2017;65:527-31.","DOI":"10.4103\/neuroindia.NI_907_15"},{"key":"ref=20","doi-asserted-by":"crossref","unstructured":"20. Tiwari AK, Bhardwaj G, Aggarwal G, Arora D, Dara RC, Acharya DP, et al. Changing trends in therapeutic plasmapheresis: An Indian perspective. Ther Apher Dial 2017;21:500-6.","DOI":"10.1111\/1744-9987.12549"},{"key":"ref=21","doi-asserted-by":"crossref","unstructured":"21. Tiwari AK, Dara RC, Pandey P, Arora D, Rawat G, Raina V, et al. Change in therapeutic apheresis practices: Role of continuing medical education (CME). J Clin Apher 2016;31:16-21.","DOI":"10.1002\/jca.21397"}],"container-title":["Indian Journal of Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijccm.org\/doi\/pdf\/10.4103\/ijccm.IJCCM_177_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T06:47:55Z","timestamp":1719730075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijccm.org\/doi\/10.4103\/ijccm.IJCCM_177_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":21,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017]]}},"alternative-id":["10.4103\/ijccm.IJCCM_177_17"],"URL":"https:\/\/doi.org\/10.4103\/ijccm.ijccm_177_17","relation":{},"ISSN":["0972-5229","1998-359X"],"issn-type":[{"value":"0972-5229","type":"print"},{"value":"1998-359X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}